-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to Anticoagulants are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for Anticoagulants.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- Genetic determinants of response to warfarin during initial anticoagulation.
Schwarz UI, Ritchie MD, Bradford Y, Li C, Dudek SM, Frye-Anderson A, Kim RB, Roden DM, Stein CM
(2008) N Engl J Med 358: 999-1008 - Factor XI antisense oligonucleotide for prevention of venous thrombosis.
Büller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, Segers A, Verhamme P, Weitz JI, FXI-ASO TKA Investigators
(2015) N Engl J Med 372: 232-40 - Estimation of the warfarin dose with clinical and pharmacogenetic data.
International Warfarin Pharmacogenetics Consortium, Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE, Lee MT, Limdi NA, Page D, Roden DM, Wagner MJ, Caldwell MD, Johnson JA
(2009) N Engl J Med 360: 753-64 - Clinical problem-solving. High time for action.
Kallianpur AR, Poehling KA, Dittus RS
(2001) N Engl J Med 344: 48-51 - Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.
Perera MA, Cavallari LH, Limdi NA, Gamazon ER, Konkashbaev A, Daneshjou R, Pluzhnikov A, Crawford DC, Wang J, Liu N, Tatonetti N, Bourgeois S, Takahashi H, Bradford Y, Burkley BM, Desnick RJ, Halperin JL, Khalifa SI, Langaee TY, Lubitz SA, Nutescu EA, Oetjens M, Shahin MH, Patel SR, Sagreiya H, Tector M, Weck KE, Rieder MJ, Scott SA, Wu AH, Burmester JK, Wadelius M, Deloukas P, Wagner MJ, Mushiroda T, Kubo M, Roden DM, Cox NJ, Altman RB, Klein TE, Nakamura Y, Johnson JA
(2013) Lancet 382: 790-6 - A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.
Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, Larson MG, Kannel WB, Benjamin EJ
(2003) JAMA 290: 1049-56 - Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48.
Gupta DK, Shah AM, Giugliano RP, Ruff CT, Antman EM, Grip LT, Deenadayalu N, Hoffman E, Patel I, Shi M, Mercuri M, Mitrovic V, Braunwald E, Solomon SD, Effective aNticoaGulation with factor xA next GEneration in AF-Thrombolysis In Myocardial Infarction 48 Echocardiographic Study Investigators
(2014) Eur Heart J 35: 1457-65 - Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week.
Mosarla RC, Vaduganathan M, Qamar A, Moslehi J, Piazza G, Giugliano RP
(2019) J Am Coll Cardiol 73: 1336-1349 - 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines
(2014) J Am Coll Cardiol 64: e1-76 - Detection of factor X activation in humans.
Bauer KA, Kass BL, ten Cate H, Bednarek MA, Hawiger JJ, Rosenberg RD
(1989) Blood 74: 2007-15 - A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, Sun MF, White-Adams TC, Smith SA, Hanson SR, McCarty OJ, Renné T, Gruber A, Gailani D
(2010) Blood 116: 3981-9 - Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.
Daneshjou R, Gamazon ER, Burkley B, Cavallari LH, Johnson JA, Klein TE, Limdi N, Hillenmeyer S, Percha B, Karczewski KJ, Langaee T, Patel SR, Bustamante CD, Altman RB, Perera MA
(2014) Blood 124: 2298-305 - Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy.
Gong IY, Tirona RG, Schwarz UI, Crown N, Dresser GK, Larue S, Langlois N, Lazo-Langner A, Zou G, Roden DM, Stein CM, Rodger M, Carrier M, Forgie M, Wells PS, Kim RB
(2011) Blood 118: 3163-71 - Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis.
Tucker EI, Verbout NG, Leung PY, Hurst S, McCarty OJ, Gailani D, Gruber A
(2012) Blood 119: 4762-8 - Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.
Chan KE, Lazarus JM, Thadhani R, Hakim RM
(2009) J Am Soc Nephrol 20: 2223-33 - Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.
Chan KE, Lazarus JM, Thadhani R, Hakim RM
(2009) J Am Soc Nephrol 20: 872-81 - Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy.
Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK
(2001) Kidney Int 60: 777-85 - Heparin-functionalized polymer graft surface eluting MK2 inhibitory peptide to improve hemocompatibility and anti-neointimal activity.
Lee Y, Le Thi P, Seon GM, Ryu SB, Brophy CM, Kim Y, Park JC, Park KD, Cheung-Flynn J, Sung HJ
(2017) J Control Release 266: 321-330 - Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice.
Bailey DG, Dresser GK, Leake BF, Kim RB
(2007) Clin Pharmacol Ther 81: 495-502 - Pharmacogenetic Implementation Lessons From the "Real World".
Roden DM
(2017) Clin Pharmacol Ther 102: 25-27 - The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.
Perera MA, Gamazon E, Cavallari LH, Patel SR, Poindexter S, Kittles RA, Nicolae D, Cox NJ
(2011) Clin Pharmacol Ther 89: 408-15 - Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.
Schwarz UI, Stein CM
(2006) Clin Pharmacol Ther 80: 7-12 - Factor XI as a target for antithrombotic therapy.
Bane CE, Gailani D
(2014) Drug Discov Today 19: 1454-8 - Intrinsic pathway of coagulation and arterial thrombosis.
Gailani D, Renné T
(2007) Arterioscler Thromb Vasc Biol 27: 2507-13 - A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical record.
Karnes JH, Cronin RM, Rollin J, Teumer A, Pouplard C, Shaffer CM, Blanquicett C, Bowton EA, Cowan JD, Mosley JD, Van Driest SL, Weeke PE, Wells QS, Bakchoul T, Denny JC, Greinacher A, Gruel Y, Roden DM
(2015) Thromb Haemost 113: 772-81 - The effect of anticoagulants on cancer risk and survival: systematic review.
Tagalakis V, Blostein M, Robinson-Cohen C, Kahn SR
(2007) Cancer Treat Rev 33: 358-68 - Sustained microgravity reduces intrinsic wound healing and growth factor responses in the rat.
Davidson JM, Aquino AM, Woodward SC, Wilfinger WW
(1999) FASEB J 13: 325-9 - Prescribed versus delivered dialysis in acute renal failure patients.
Evanson JA, Himmelfarb J, Wingard R, Knights S, Shyr Y, Schulman G, Ikizler TA, Hakim RM
(1998) Am J Kidney Dis 32: 731-8 - Continuous arteriovenous hemofiltration in acute renal failure.
Golper TA
(1985) Am J Kidney Dis 6: 373-86 - Hemodialysis: techniques and prescription.
Ikizler TA, Schulman G
(2005) Am J Kidney Dis 46: 976-81 - Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation.
Massion PB, Peters P, Ledoux D, Zimermann V, Canivet JL, Massion PP, Damas P, Gothot A
(2012) Intensive Care Med 38: 1326-35 - Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans.
Hernandez W, Gamazon ER, Aquino-Michaels K, Patel S, O'Brien TJ, Harralson AF, Kittles RA, Barbour A, Tuck M, McIntosh SD, Douglas JN, Nicolae D, Cavallari LH, Perera MA
(2014) Pharmacogenomics J 14: 223-8 - Dialysate ... Ho-hum!
Golper TA, Ward RA
(2009) Clin J Am Soc Nephrol 4: 1403-4 - Safety and efficacy of regional citrate anticoagulation during 8-hour sustained low-efficiency dialysis.
Clark JA, Schulman G, Golper TA
(2008) Clin J Am Soc Nephrol 3: 736-42 - Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis.
Claure-Del Granado R, Macedo E, Chertow GM, Soroko S, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL
(2011) Clin J Am Soc Nephrol 6: 467-75 - The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population.
Vear SI, Ayers GD, Van Driest SL, Sidonio RF, Stein CM, Ho RH
(2014) Br J Haematol 165: 832-5 - Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.
Sarilla S, Habib SY, Kravtsov DV, Matafonov A, Gailani D, Verhamme IM
(2010) J Biol Chem 285: 8278-89 - Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6.
Yun CH, Kim KH, Calcutt MW, Guengerich FP
(2005) J Biol Chem 280: 12279-91 - A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids.
Henry BL, Monien BH, Bock PE, Desai UR
(2007) J Biol Chem 282: 31891-9 - Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators.
Califf RM, Woodlief LH, Harrell FE, Lee KL, White HD, Guerci A, Barbash GI, Simes RJ, Weaver WD, Simoons ML, Topol EJ
(1997) Am Heart J 133: 630-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
